Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $4,541.0M | $5,764.0M | $6,354.0M | $5,831.0M | $4,703.0M | $8,782.0M | $8,260.0M | $6,524.0M | $2,329.0M | $5,342.0M | $4,306.0M | $536.0M | $1,831.0M | $1,958.0M | $1,247.0M | $509.0M | $2,193.0M | $3,763.0M | $7,237.0M | $6,567.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, AstraZeneca PLC's last 12-month Free Cash Flow is $6,757.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, AstraZeneca PLC's Free Cash Flow growth was (3.2%). The average annual Free Cash Flow growth rates for AstraZeneca PLC have been 20.2% over the past three years, 38.3% over the past five years.
Over the last year, AstraZeneca PLC's Free Cash Flow growth was (3.2%), which is lower than industry growth of (0.2%). It indicates that AstraZeneca PLC's Free Cash Flow growth is Bad.